FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093522690> ?p ?o ?g. }

• W2093522690 endingPage "518" @default.
• W2093522690 startingPage "505" @default.
• W2093522690 abstract "Five commercially available insect sprays were applied in a model room. Spraying was performed in accordance with the manufacturers' instructions and in an overdosed manner in order to simulate worst-case conditions or an unforeseeable misuse. In addition, we examined electro-vaporizers. The Respicon aerosol monitoring system was applied to determine inhalation exposure. During normal spraying (10 seconds) and during the following 2-3 minutes, exposure concentrations ranged from 70 to 590 microg/m3 for the pyrethroids tetramethrin, d-phenothrin, cyfluthrin, bioallethrin, and the pyrethrins. Calculated inhalable doses were 2-16 microg. A concentration of approximately 850 microg chlorpyrifos/m(3) (inhalable dose: approximately 20 microg) was determined when the Contra insect fly spray was applied. Highest exposure concentrations (1100-2100 microg/m3) were measured for piperonyl butoxide (PBO), corresponding to an inhalation intake of 30-60microg. When simulating worst-case conditions, exposure concentrations of 200-3400microg/m3 and inhalable doses of 10-210microg were determined for the various active substances. Highest concentrations (4800-8000 microg/m3) were measured for PBO (inhalable: 290-480 microg). By applying the electro-vaporizer Nexa Lotte plug-in mosquito killer concentrations for d-allethrin were in the range of 5-12microg/m3 and 0.5-2 microg/m3 for PBO while with the Paral plug-in mosquito killer concentrations of 0.4-5microg/m3 for pyrethrins and 1-7 microg/m3 for PBO were measured. Potential dermal exposures were determined using exposure pads. Between 80 and 1000microg active substance (tetramethrin, phenothrin, cyfluthrin, bioallethrin, pyrethrins, chlorpyrifos) were deposited on the clothing of the total body surface area of the spray user. Highest levels (up to 3000 microg) were determined for PBO. Worst-case uses of the sprays led to 5-9 times higher concentrations. Also a 2-hour stay nearby an operating electro-vaporizer led to a contamination of the clothing (total amounts on the whole body were 450 microg d-allethrin and 50 microg PBO for Nexa Lotte plug-in mosquito killer and 80 microg pyrethrins and 190 microg PBO for Paral plug-in mosquito killer). Human biomonitoring data revealed urine concentrations of the metabolite (E)-trans-chrysanthemum dicarboxylic acid ((E)-trans-CDCA) between 1.7 microg/l and 7.1 microg/l after 5 minutes of exposure to the different sprays. Also the use of electro-vaporizers led to (E)-trans-CDCA concentrations in the urine in the range of 1.0 microg/l to 6.2 microg/l (1-3 hours exposure period). The exposure data presented can be used for performing human risk assessment when these biocidal products were applied indoors. The airborne concentrations of the non-volatile active chemical compounds could be predicted from first principles using a deterministic exposure model (SprayExpo)." @default.
• W2093522690 created "2016-06-24" @default.
• W2093522690 creator A5038633132 @default.
• W2093522690 creator A5040395718 @default.
• W2093522690 creator A5057083197 @default.
• W2093522690 creator A5064356435 @default.
• W2093522690 creator A5078401709 @default.
• W2093522690 date "2009-09-01" @default.
• W2093522690 modified "2023-09-23" @default.
• W2093522690 title "Use of biocidal products (insect sprays and electro-vaporizer) in indoor areas – Exposure scenarios and exposure modeling" @default.
• W2093522690 cites W1981643684 @default.
• W2093522690 cites W1983876489 @default.
• W2093522690 cites W1995078576 @default.
• W2093522690 cites W2009254035 @default.
• W2093522690 cites W2013076208 @default.
• W2093522690 cites W2026838356 @default.
• W2093522690 cites W2032616979 @default.
• W2093522690 cites W2039958522 @default.
• W2093522690 cites W2052173618 @default.
• W2093522690 cites W2072047889 @default.
• W2093522690 cites W2084866392 @default.
• W2093522690 cites W2100854531 @default.
• W2093522690 cites W2124884999 @default.
• W2093522690 cites W2316435997 @default.
• W2093522690 cites W51527241 @default.
• W2093522690 doi "https://doi.org/10.1016/j.ijheh.2009.02.001" @default.
• W2093522690 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19345645" @default.
• W2093522690 hasPublicationYear "2009" @default.
• W2093522690 type Work @default.
• W2093522690 sameAs 2093522690 @default.
• W2093522690 citedByCount "15" @default.
• W2093522690 countsByYear W20935226902012 @default.
• W2093522690 countsByYear W20935226902013 @default.
• W2093522690 countsByYear W20935226902014 @default.
• W2093522690 countsByYear W20935226902016 @default.
• W2093522690 countsByYear W20935226902017 @default.
• W2093522690 countsByYear W20935226902018 @default.
• W2093522690 countsByYear W20935226902019 @default.
• W2093522690 countsByYear W20935226902020 @default.
• W2093522690 countsByYear W20935226902021 @default.
• W2093522690 countsByYear W20935226902023 @default.
• W2093522690 crossrefType "journal-article" @default.
• W2093522690 hasAuthorship W2093522690A5038633132 @default.
• W2093522690 hasAuthorship W2093522690A5040395718 @default.
• W2093522690 hasAuthorship W2093522690A5057083197 @default.
• W2093522690 hasAuthorship W2093522690A5064356435 @default.
• W2093522690 hasAuthorship W2093522690A5078401709 @default.
• W2093522690 hasConcept C142724271 @default.
• W2093522690 hasConcept C161176658 @default.
• W2093522690 hasConcept C178790620 @default.
• W2093522690 hasConcept C185592680 @default.
• W2093522690 hasConcept C2776035571 @default.
• W2093522690 hasConcept C2776304672 @default.
• W2093522690 hasConcept C2776954882 @default.
• W2093522690 hasConcept C2777338454 @default.
• W2093522690 hasConcept C2778635518 @default.
• W2093522690 hasConcept C2779777708 @default.
• W2093522690 hasConcept C2781208240 @default.
• W2093522690 hasConcept C29730261 @default.
• W2093522690 hasConcept C33070731 @default.
• W2093522690 hasConcept C42219234 @default.
• W2093522690 hasConcept C6557445 @default.
• W2093522690 hasConcept C71924100 @default.
• W2093522690 hasConcept C86803240 @default.
• W2093522690 hasConceptScore W2093522690C142724271 @default.
• W2093522690 hasConceptScore W2093522690C161176658 @default.
• W2093522690 hasConceptScore W2093522690C178790620 @default.
• W2093522690 hasConceptScore W2093522690C185592680 @default.
• W2093522690 hasConceptScore W2093522690C2776035571 @default.
• W2093522690 hasConceptScore W2093522690C2776304672 @default.
• W2093522690 hasConceptScore W2093522690C2776954882 @default.
• W2093522690 hasConceptScore W2093522690C2777338454 @default.
• W2093522690 hasConceptScore W2093522690C2778635518 @default.
• W2093522690 hasConceptScore W2093522690C2779777708 @default.
• W2093522690 hasConceptScore W2093522690C2781208240 @default.
• W2093522690 hasConceptScore W2093522690C29730261 @default.
• W2093522690 hasConceptScore W2093522690C33070731 @default.
• W2093522690 hasConceptScore W2093522690C42219234 @default.
• W2093522690 hasConceptScore W2093522690C6557445 @default.
• W2093522690 hasConceptScore W2093522690C71924100 @default.
• W2093522690 hasConceptScore W2093522690C86803240 @default.
• W2093522690 hasIssue "5" @default.
• W2093522690 hasLocation W20935226901 @default.
• W2093522690 hasLocation W20935226902 @default.
• W2093522690 hasOpenAccess W2093522690 @default.
• W2093522690 hasPrimaryLocation W20935226901 @default.
• W2093522690 hasRelatedWork W1991522283 @default.
• W2093522690 hasRelatedWork W2030098010 @default.
• W2093522690 hasRelatedWork W2036120252 @default.
• W2093522690 hasRelatedWork W2066067328 @default.
• W2093522690 hasRelatedWork W2093522690 @default.
• W2093522690 hasRelatedWork W2315082572 @default.
• W2093522690 hasRelatedWork W2319469510 @default.
• W2093522690 hasRelatedWork W2323608223 @default.
• W2093522690 hasRelatedWork W2332686965 @default.
• W2093522690 hasRelatedWork W2895687102 @default.
• W2093522690 hasVolume "212" @default.
• W2093522690 isParatext "false" @default.

• next